-
-
-
-
-
-
-
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test
-
-
-
-
-
-
-
Veracyte, Inc (VCYT) PT Raised to $37 at Needham
-
-
-
-
-
-
-
Veracyte Announces Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Veracyte Announces Fourth Quarter and Full-Year 2021 Financial Results
-
-
-
-
-
-
-
Veracyte (VCYT) Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
-
-
-
-
-
-
-
Veracyte, Inc (VCYT) In the Midst of a Sea of Catalysts, Needham Reiterates Buy
-
-
-
-
-
-
-
Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results
-
1,178,414 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

